Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Wal-Mart Tops Estimates on Double-Digit Online Growth
22:42 - Wal-Mart topped fourth-quarter estimates as the retailer posted its third straight quarter of growth in online sales following last year's $3.3 billion acquisition of Jet.com. Bloomberg Gadfly columnist Shelly Banjo and Paul Richards, president at Medley Global Advisors, examine the results on "Bloomberg Daybreak: Americas." (Banjo is a Bloomberg Gadfly columnist. The opinions expressed are her own.) (Source: Bloomberg)
  • Harvard's Burns Sees Mixed U.S. Messages for Europe
  • Economist O'Sullivan Asks Why Fed Wouldn't Go in March
  • OPEC Has Lost Market Leverage, Says CFR's Richard Haass